Alexander Villacastin
Adult Health · Citrus Springs, FLNPI 1174720619
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,638 of the $15,140 with a category attached, or 83.5%. 41 manufacturers reported payments, led by AbbVie at 30.2% of the total. Reporting peaked in 2022 at $5,470 and has fallen 65.3% since, to $1,898 in 2025. Among adult health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 547 payments — averaging $27.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- AstraZeneca$2K
- Novo Nordisk$2K
- Pfizer$923
- Boehringer Ingelheim$697
- Johnson & Johnson$682
- plus $5K from 35 others
What the payments were for
- Speaking & faculty fees$2,50017%
- Food & beverage$12,63883%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,140 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 184 | $237,001 |
| OzempicSemaglutide | 114 | $204,556 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 95 | $127,136 |
| JardianceEmpagliflozin | 93 | $98,954 |
| TrulicityDulaglutide | 59 | $96,983 |
| EliquisApixaban | 90 | $82,510 |
| MounjaroTirzepatide | 36 | $41,074 |
| MyrbetriqMirabegron | 37 | $39,040 |
| XifaxanRifaximin | 13 | $38,498 |
| XareltoRivaroxaban | 30 | $37,798 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $33,855 |
| Repatha SureclickEvolocumab | 37 | $32,333 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $31,647 |
| LinzessLinaclotide | 19 | $26,776 |
| RybelsusSemaglutide | 25 | $24,996 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,657 | $281,624234 claims |
| Novo NordiskOzempic, Rybelsus | $1,649 | $229,552139 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $459 | $151,683126 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $529 | $138,05795 claims |
| PfizerEliquis, Nurtec Odt | $923 | $106,909102 claims |
| Boehringer IngelheimJardiance | $697 | $98,95493 claims |
| Astellas Pharma US IncMyrbetriq | $231 | $39,04037 claims |
| Johnson & JohnsonXarelto | $682 | $37,79830 claims |
| AbbVieLinzess | $4,579 | $26,77619 claims |
| AmgenProlia | $431 | $22,06913 claims |
| NovartisEntresto | $272 | $15,64617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,237 adult health providers in Florida.
Other adult health in Citrus Springs
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Cynthia OteroMaitland$31K
- Jennifer GodshallTampa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.